| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3348049 | Diagnostic Microbiology and Infectious Disease | 2009 | 4 Pages |
Abstract
Voriconazole susceptibility testing was performed on 7191 Candida spp. from 78 centers worldwide between 2004 and 2007. Voriconazole was very active in vitro (MIC50/MIC90, 0.008/0.25 μg/mL; 98% susceptible). In comparison to 5866 Candida spp. isolates collected during global surveillance from 1997 to 2001, there were no changes in voriconazole mean MIC or MIC distribution.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Daniel J. Diekema, Shawn A. Messer, Richard J. Hollis, Linda Boyken, Shailesh Tendolkar, Jennifer Kroeger, Ronald N. Jones, Michael A. Pfaller,